HEPHAISTOS-Pharma, a biotechnology company developing new-generation
immunotherapies targeting innate immunity to increase patient cure rates, has
4.5 million seed financing round, in which Angels Santé participated, to finance
Angels Santé, to finance industrialization and advance its lead candidate ONCO-
Boost into the clinic.